Microbot Medical (MBOT) Cash from Investing Activities (2010 - 2026)

Microbot Medical has reported Cash from Investing Activities for 17 years, with the latest figure at $5.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 120.12% year-over-year to $5.0 million; the trailing twelve-month figure through Mar 2026 stood at -$42.6 million (down 93.36% YoY), and the FY2025 full-year result was -$72.4 million, down 4809.43% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $5.0 million, up from -$1.5 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $5.0 million in Q1 2026, with the low at -$44.7 million in Q3 2025.
• Historically, Cash from Investing Activities has averaged -$4.0 million across 5 years, with a median of -$62000.0 in 2022.
• The largest YoY upside for Cash from Investing Activities was 18118.75% in 2023 against a maximum downside of 51340.0% in 2023.
• Microbot Medical's Cash from Investing Activities stood at -$3.8 million in 2022, then soared by 178.79% to $3.0 million in 2023, then slumped by 49.44% to $1.5 million in 2024, then tumbled by 202.54% to -$1.5 million in 2025, then jumped by 425.96% to $5.0 million in 2026.
• The last three Cash from Investing Activities figures came in at $5.0 million (Q1 2026), -$1.5 million (Q4 2025), and -$44.7 million (Q3 2025), per Business Quant data.